Rekvina Laboratories Appoints Subrata Samanta as Chief Financial Officer
Rekvina Laboratories Ltd 路 Change in Management 路 08 Oct 2026, 1:02 am
Rekvina Laboratories Appoints Subrata Samanta as Chief Financial Officer Rekvina Laboratories Limited has appointed Mr. Subrata Samanta as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP), effective 7th Oct'26. Mr. Samanta brings over 20 years of experience in finance, costing, budgeting, taxation, and financial planning across major organizations, including GNFC, Lupin, Glenmark, Intas, and PwC. An Associate Cost and Management Accountant (ACMA) with an M.Com. from Calcutta University, his background includes SAP implementations, strategic financial management, and operational cost optimization. He has confirmed he is not debarred from holding office by SEBI.
Original exchange filing (PDF)
More announcements from Rekvina Laboratories Ltd
- Reg. 32 Statement of Deviation & Variation 路 13 Nov 2026
- Appointment of Ms. Bhagyshree as a company Secretary and Compliance Officer w.e.f. 16.11.2026. 路 13 Nov 2026
- Financial Result for QTR2 路 13 Nov 2026
- Outcome of Board Meeting 路 13 Nov 2026
- Rekvina Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve Financial Result for QTR2 路 13 Nov 2026
- Intimation regarding Temporary Shutdown of Manufacturing Facility for Renovation, Upgradation and Installation of an Additional Vial Manufacturing Line. 路 27 Oct 2026
- AGM Voting Results along-with Scrutinizer Report on E-Voting 路 30 Sept 2026
- Summary of Proceeding of Annual General Meeting 路 29 Sept 2026
